Thorne HealthTech, Inc. (THRN)

Private equity firm L Catterton has appointed former Vitamin Shoppe CEO Colin Watts as Thorne HealthTech's next leader following its $680 million acquisition of the U.S. health and wellness company in October.

NEW YORK , Oct. 16, 2023 /PRNewswire/ -- L Catterton, a leading global consumer-focused investment firm, today announced the successful completion of its acquisition of Thorne HealthTech, Inc. ("Thorne") (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness. "As consumer investors, we closely follow enduring secular trends, including the consumer's increasing prioritization of health and wellness," said Marc Magliacano, co-Managing Partner of the Flagship Fund at L Catterton.

NEW YORK , Oct. 13, 2023 /PRNewswire/ -- L Catterton and Thorne HealthTech, Inc. ("Thorne") (NASDAQ: THRN) today announced that the tender offer to purchase all of the issued and outstanding shares of Thorne's common stock ("Shares") for $10.20 per Share, net to the seller in cash, without interest and less any required withholding taxes (the "Offer"), expired as scheduled at one minute past 11:59 p.m., Eastern Time, on October 12, 2023 and was not extended (such date and time, the "Expiration Time").

NEW YORK , Oct. 13, 2023 /PRNewswire/ -- L Catterton and Thorne HealthTech, Inc. ("Thorne") (NASDAQ: THRN) today announced that the tender offer to purchase all of the issued and outstanding shares of Thorne's common stock ("Shares") for $10.20 per Share, net to the seller in cash, without interest and less any required withholding taxes (the "Offer"), expired as scheduled at one minute past 11:59 p.m., Eastern Time, on October 12, 2023 and was not extended (such date and time, the "Expiration Time").

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Thorne HealthTech, Inc. (NasdaqGS: THRN) to L Catterton. Under the terms of the proposed transaction, shareholders of Thorne will receive $10.20 in cash for each share of Thorne that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the con.

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Thorne HealthTech, Inc. (NasdaqGS: THRN) to L Catterton. Under the terms of the proposed transaction, shareholders of Thorne will receive $10.20 in cash for each share of Thorne that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the con.

MILWAUKEE , Aug. 28, 2023 /PRNewswire/ -- Ademi LLP is investigating Thorne (Nasdaq: THRN) for possible breaches of fiduciary duty and other violations of law in its transaction with L Catterton. Click here to learn how to join the action https://www.ademilaw.com/case/ thorne-healthtech-inc or call Guri Ademi toll-free at 866-264-3995.

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Thorne HealthTech, Inc. (NASDAQ: THRN) to L Catterton for $10.20 per share in cash is fair to Thorne shareholders. Halper Sadeh encourages Thorne shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Thorne and its b.

Thorne HealthTech Inc. stock THRN, +5.97% was up 29% in premarket trades on Monday after it said it agreed to be taken private by L Catterton for $10.20 a share in cash in a deal valued at $680 million. The price amounts to a premium of 94% over Thorne HealthTech's unaffected closing share price on July 20.

L Catterton to Commence a Tender Offer for all of Thorne's Outstanding Shares of Common Stock Thorne Stockholders to Receive $10.20 per Share in Cash, Representing a 94% Premium to the Unaffected Price Independent Special Committee and Thorne Board of Directors Unanimously Approve Transaction and Recommend that All Stockholders Tender Their Shares in the Tender Offer  NEW YORK, Aug. 28, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne" or the "Company") (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, announced today that it has entered into a definitive agreement under which L Catterton, a leading global consumer-focused investment firm, will commence a tender offer to acquire all outstanding shares of common stock of Thorne for $10.20 per share in cash. The transaction value of approximately $680 million represents a 94% premium to the unaffected closing share price on July 20, 2023, and a 113% premium to the 30-day volume weighted average price as of the unaffected date of July 20, 2023.

Investors interested in Medical Services stocks are likely familiar with Thorne Healthtech, Inc. (THRN) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for their buck right now?

Thorne HealthTech, Inc (NASDAQ:THRN ) Q2 2023 Earnings Conference Call August 8, 2023 5:00 PM ET Company Participants Thomas Wilson - Vice President, Investor Relations Paul Jacobson - Chief Executive Officer Saloni Varma - Chief Financial Officer Tom McKenna - Chief Operating Officer Conference Call Participants Susan Anderson - Canaccord Genuity Patrick McNally - Evercore Operator Thank you for standing by. My name is Dina, and I will be your conference operator for today.

Company Withdraws Participation in the Canaccord Genuity 43rd Annual Growth Conference on Aug. 10 NEW YORK , Aug. 1, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, will release its second quarter 2023 financial results after market close on Tuesday, Aug. 8, 2023. The company will host a conference call to discuss its results on Tuesday, Aug. 8, 2023, at 5:00 p.m.

NEW YORK , July 28, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne") (the "Company") (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, announced today that it will participate in the Canaccord Genuity 43rd Annual Growth Conference in Boston. On Thursday, Aug. 10, at 10:30 a.m.

The conventional definition of a penny stock is one that trades below $1. However, it's more common to define a penny stock as any stock that trades for less than $5.

Thorne HealthTech, Inc. (NASDAQ:THRN ) Q1 2023 Earnings Conference Call May 11, 2023 5:30 PM ET Company Participants Thomas Wilson - VP, IR Paul Jacobson - CEO Saloni Varma - CFO Tom McKenna - COO Michelle Crow - CMO Conference Call Participants Sean Dodge - RBC Elizabeth Anderson - Evercore Susan Anderson - Canaccord Steven Mah - TD Cowen Operator Good afternoon. Thank you for attending today's Thorne HealthTech, Inc. First Quarter 2020 Earnings Call.